Showing results (91-100 of 214) with videos related to

Sort By:
Pageof 22
Cancer Research|October 6, 2005
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancerSanjeev Banerjee, Yuxiang Zhang, Shadan Ali, et al.
American Journal of Clinical Oncology|June 5, 2010
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experienceNazik Hammad, Lance K Heilbrun, Sachin Gupta, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancerPhilippe Rougier, Hanno Riess, Robert Manges, et al.
Cancers|July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to BedsideMd Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.
Future Oncology (London, England)|September 13, 2019
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreasPhilip A Philip, Marc E Buyse, Angela T Alistar, et al.
Molecular Cancer Therapeutics|October 5, 2007
Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cellsK M Wahidur Rahman, Shadan Ali, Amro Aboukameel, et al.
Cancer|July 19, 2006
Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancerHoward S Hochster, Daniel G Haller, Aimery de Gramont, et al.
Cancer|June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary siteBryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
Cancer|September 29, 2011
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Kyle D Holen, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primaryBasil F El-Rayes, Anthony F Shields, Mark Zalupski, et al.
Pageof 22